CN Patent

CN105153128A — 一种合成达卡他韦中间体的新方法

Assigned to SHANGHAI FOREFRONT PHARMA · Expires 2015-12-16 · 10y expired

What this patent protects

本发明提供了一种合成达卡他韦中间体的新方法，具体地，本发明提供了一种如式1的化合物的制备方法，所述的方法以联苯和卤代酰氯作为起始原料，避免了成本高的反应原料的使用，制备方法简单，安全性好，适合工业化生产。

USPTO Abstract

本发明提供了一种合成达卡他韦中间体的新方法，具体地，本发明提供了一种如式1的化合物的制备方法，所述的方法以联苯和卤代酰氯作为起始原料，避免了成本高的反应原料的使用，制备方法简单，安全性好，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN105153128A
Jurisdiction
CN
Classification
—
Expires
2015-12-16
Drug substance claim
No
Drug product claim
No
Assignee
SHANGHAI FOREFRONT PHARMA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.